| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10941000 | Immunobiology | 2013 | 7 Pages |
Abstract
Serum YKL-40 is a predictor of long-term mortality in patients with stable CAD independent of common risk factors and ln(hs-CRP) and ln(NT-proBNP). Serum YKL-40 can be used for prognostication in these patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Marina Harutyunyan, Jens P. Gøtze, Per Winkel, Julia S. Johansen, Jørgen Fischer Hansen, Gorm Boje Jensen, Jørgen Hilden, Erik Kjøller, Hans J. Kolmos, Christian Gluud, Jens Kastrup,